the sun malaysia ipaper logo 150x150
Thursday, July 2, 2026
28.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

S&P 500 and Nasdaq hit record highs ahead of Fed rate decision

NEW YORK: Wall Street stocks advanced on Monday with the S&P 500 and Nasdaq Composite reaching new all-time highs amid growing anticipation of a Federal Reserve interest rate cut.

Investor optimism was further bolstered by positive developments from US-China economic discussions held in Madrid.

The Dow Jones Industrial Average rose 0.1% to close at 45,883.45, while the broad-based S&P 500 Index gained 0.5% to finish at 6,615.28.

The technology-focused Nasdaq Composite Index surged 0.9% to end the trading session at 22,348.75.

Market movements reflected strong investor expectations that the Federal Reserve will implement its first interest rate reduction of 2025 following its two-day policy meeting concluding on Wednesday.

Art Hogan of B. Riley Wealth Management noted that markets would likely remain in a wait-and-see pattern until the Fed’s official announcement.

Investors are particularly focused on determining whether the central bank will initiate a full cycle of rate cuts or implement only a single reduction.

In parallel developments, senior economic officials from Washington and Beijing announced they had reached a framework agreement to resolve their ongoing dispute concerning TikTok.

Tesla shares jumped 3.6% after CEO Elon Musk revealed he had purchased approximately $1 billion worth of additional shares in the electric vehicle manufacturer. – AFP

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings